Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -21.94% vs 24.52% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -54.25% vs 43.07% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "180.40",
          "val2": "231.10",
          "chgp": "-21.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "25.50",
          "val2": "89.50",
          "chgp": "-71.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.90",
          "val2": "1.30",
          "chgp": "-30.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "30.70",
          "val2": "67.10",
          "chgp": "-54.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "141.30%",
          "val2": "284.50%",
          "chgp": "-14.32%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 6.15% vs 2.98% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 23.95% vs 0.50% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "707.50",
          "val2": "666.50",
          "chgp": "6.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "220.20",
          "val2": "199.30",
          "chgp": "10.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "11.20",
          "val2": "15.30",
          "chgp": "-26.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-20.70",
          "val2": "-6.90",
          "chgp": "-200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "200.80",
          "val2": "162.00",
          "chgp": "23.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "174.50%",
          "val2": "180.80%",
          "chgp": "-0.63%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

180.40

231.10

-21.94%

Operating Profit (PBDIT) excl Other Income

25.50

89.50

-71.51%

Interest

0.90

1.30

-30.77%

Exceptional Items

0.00

0.00

Consolidate Net Profit

30.70

67.10

-54.25%

Operating Profit Margin (Excl OI)

141.30%

284.50%

-14.32%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is -21.94% vs 24.52% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is -54.25% vs 43.07% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

707.50

666.50

6.15%

Operating Profit (PBDIT) excl Other Income

220.20

199.30

10.49%

Interest

11.20

15.30

-26.80%

Exceptional Items

-20.70

-6.90

-200.00%

Consolidate Net Profit

200.80

162.00

23.95%

Operating Profit Margin (Excl OI)

174.50%

180.80%

-0.63%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 6.15% vs 2.98% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 23.95% vs 0.50% in Dec 2023

All Annual Results